Please assess the completion status of the following clinical trial:

Trial Title: Validation Study of Covariates Model (VaSCoM) for Propofol

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged over 18 years~* ASA I/II~* Elective non-cardiac surgery expected to last longer than 30 minutes~Exclusion Criteria:~* Patient refusal or unable to consent~* Premedication, sedative or anaesthetic in the previous 12 hours~* Pre-operative GCS less than 15~* ASA III/IV~* Allergy to constituents of propofol~* Excess alcohol intake~* Drug abuse~* Mental retardation~* Difficult airway~* BMI over 35

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Low-high-low blood target concentration (Type: EXPERIMENTAL): Patients in the low-high-low group will receive an infusion of propofol with an initial blood target concentration of 2 mcg/ml. After 15 minutes the target will be increased to 5 mcg/ml and after a further 15 minutes the target will be reduced back to 2 mcg/ml for a further 15 to 30 minutes.
- High-low-high target blood concentration (Type: EXPERIMENTAL): Patients in the high-low-high group will receive an infusion of propofol with an initial blood target concentration of 5 mcg/ml. After 15 minutes the target will be reduced to 2 mcg/ml and after a further 15 minutes the target will be increased back to 5 mcg/ml for a further 15 to 30 minutes.

Based on this trial design, predict the completion outcome and termination type (if applicable).